GREM1 has also been reported to bind to and activate epidermal growth factor receptor (EGFR) in SKBR3 human breast cancer cells that overexpress HER2/EGFR (Park et al. 2020) (Fig. 1A). Here, EGFR is linked to breast carcinoma.